Conotoxins are well known for their highly variable structures and functions. Here we report the identification of a novel conotoxin named mr1e from Conus marmoreus. mr1e is composed of 11 amino acid residues cross-linked by two disulfide bonds (CCHSSWCKHLC). The spacing of intercysteine loops in mr1e is exactly the same as that in α4/3 conotoxins. However, the native mr1e peptide co- . Although this peptide has the same disulfide connectivity as the χ-conotoxins, their sequences do not share significant homology. Thus, mr1e could be defined as a novel conotoxin family. By intracranial injection into mice, mr1e showed an excitatory effect. The characterization of mr1e certainly enriches our understanding of conotoxins, and also opens an avenue for further structural and functional investigation.
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Cone snails are a group of predatory marine gastropods that can produce a mixture of disulfide-rich peptide neurotoxins, namely conotoxins, to prey and defense. Conotoxins are attracting increasing interest from scientists because they are highly diversified both structurally and functionally. Conotoxins can be classified into several families based on the number and pattern of disulfide bonds and their different targets, including ion channels, neurotransmitter receptors or transporters, and G-proteincoupled receptors [1, 2] . For instance, α-conotoxins have a CC-C-C pattern and act on nicotinic acetylcholine receptors [3] , whereas ω-conotoxins share a C-C-CC-C-C cysteine framework and specifically target calcium channels [4] . Because of their high specificities, some conotoxins have been applied as tool agents in neuroscience and developed as therapeutic and pharmaceutical reagents in clinical applications [5, 6] .
Conotoxins of several different families have two disulfide bonds. α-conotoxins are one of the best studied conotoxin families. They have a canonical C disulfide bond connectivity. According to the residue numbers in the two cysteine loops, α-conotoxins are further grouped into different subfamilies, of which α3/5 and α4/7 are most prominent. In addition, there are α4/6, α4/5, α4/4, and α4/3 conotoxins [7] . They all act on nicotinic acetylcholine receptors, but with distinct subtype specificity [8, 9] . τ-conotoxins have a unique CC-CC motif and also a C 1 -C 3 , C 2 -C 4 disulfide bond connectivity, but their molecular target is still elusive [10] . Recently, two other two-disulfide-bond conotoxin families were identified, ρ-conotoxin TIA acting on α1-adrenoceptor and χ-conotoxin MrIA acting on noradrenaline transporter [11] . ρ-conotoxin shares a similar cysteine framework and disulfide bond connectivity with α-conotoxin, however, χ-conotoxins have a unique C Conotoxins are a natural library of bioactive peptides with a population of approximately 50,000 of which only a small portion has been studied [12] . More research is needed to explore the remainder.
In this study, we report the purification and characterization of a novel conotoxin, mr1e, from the venom of the mollusk-hunting snail Conus marmoreus. This peptide has a CC-C-C cysteine framework, like α4/3 conotoxins, but adopts a C 1 -C 4 , C 2 -C 3 disulfide bond connectivity. Thus, mr1e might define a novel conotoxin family.
Materials and Methods

Materials
Sephadex G-15 was purchased from Amersham Biosciences (Uppsala, Sweden), Zorbax 300SB-C18 analytical HPLC columns (4.6 mm×250 mm, 9.2 mm×250 mm) were obtained from Agilent Technologies (Santa Clara, USA), and trifluoroacetic acid and acetonitrile were from Merck (Darmstadt, Germany). Reagents for aminoterminal sequencing, Fmoc-amino acids, and Fmoc-cys (Trityl)-resin were purchased from Applied Biosystems (Foster City, USA). Other reagents were of analytical grade.
Peptide purification
The venom apparatus of C. marmoreus was dissected out, cut into segments, and homogenized. The venom was extracted with 1.1% (V/V) acetic acid for 30 min at 0 ºC. The homogenate was centrifuged at 10,000 g for 10 min at 4 ºC, and the supernatant was collected. This procedure was repeated twice, and the supernatants were pooled, lyophilized, and stored at −20 ºC. For conotoxin purification, the lyophilized crude venom was dissolved with 1.1% acetic acid and briefly centrifuged, the supernatant was loaded onto a Sephadex G-15 column (2.6 cm×100 cm) and eluted with 1.1% acetic acid at a flow rate of 0.5 ml/min. The eluted fractions were pooled and further fractionated on a Zorbax 300SB-C18 semipreparative column (9.2 mm×250 mm; Agilent 1100 reverse-phase HPLC). Further purification of peptide mr1e was carried out on a Zorbax 300SB-C18 analytical column (4.6 mm×250 mm). The purity of the prepared peptide was determined by mass spectrometry.
Peptide sequencing
The purified peptide mr1e was dissolved in 0.1 M TrisHCl, 6 M guanidine-HCl (pH 8.5), and 0.01 M EDTA, and reduced with 100× overdose of dithiothreitol at 37 ºC for 2 h. Then 4 μl of 4-vinylpyridine was added. After being mixed and flushed with N 2 , the mixture was incubated at room temperature for 3 h in darkness. The alkylated peptide was then purified by HPLC. The amino acid sequence of the pyridylethylated mr1e was determined by automated Edman degradation on an ABI 491A Procise protein sequencing system (Applied Biosystems).
Molecular mass determination
The molecular mass of all the purified and synthetic peptides was analyzed by a QTrap mass spectrometer using the Enhanced MS scan type (Applied Biosystems). The mass spectrometer equipped with a TurboIonSpray Source was operated in positive ionization mode.
Peptide synthesis and refolding
The linear peptide of mr1e was synthesized by standard Fmoc chemistry. The protected peptide was independently grown on a Wang resin, using the 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluroniumhexafluorophosphate (HBTU)/N-hydroxybenzotriazole (HOBt) amino acid activation method. Solid phase peptide synthesis was carried out on a 433A peptide synthesizer (Applied Biosystems).
Two isomers of mr1e with different protecting groups on Cys pairs [Trt-C
] were synthesized. During the cleavage of synthesized peptides from the resin, the residue side chains were simultaneously deprotected except Cys (Acm). The linear peptides were oxidized at room temperature with 50 mM NH 4 AC buffer (pH 8.0) overnight to form the disulfide bond between free Cys residues. The purified monocyclic peptides were then dissolved in 10% CH 3 CN, 4% trifluoroacetic acid. Then 0.5 mg/ml iodine was added to form the second disulfide bond between Cys residues protected by Acm. The final fully disulfide bonded peptides were then purified and co-eluted with the natural mr1e.
Bioassay
The biological activity of mr1e was studied by intracranial injection into mice. The toxin mr1e was dissolved in normal saline solution at different concentrations. Male Kunming mice (4 weeks old, 25−30 g body weight) were injected intracranially with 20 μl mr1e solution (n=4 for each dose). The control animals were injected with the same volume of normal saline solution (n=4). The symptoms of injected mice were observed for 2 h.
Results mr1e purification and sequencing
The crude venom extract from C. marmoreus was first size-fractionated on a Sephadex G-15 column. The major peak was further separated by reverse-phase HPLC [ Fig. 1(A) ]. Each peak was repurified on the same C18 semipreparative column for molecular mass determination and sequencing.
The peak indicated by an arrow in Fig. 1(B) was confirmed to contain a peptide with 11 amino acid residues a f t e r b e i n g r e d u c e d a n d p y r i d y l e t h y l a t e d , CCHSSWCKHLC. The determined molecular mass of this toxin was 1301.7 Da, consistent with the calculated mass (1301.8 Da) assuming that two disulfide bonds are formed. This toxin shares the same cysteine framework with α4/ 3 conotoxins, with four and three residues in two cysteine loops, respectively. However, the disulfide bond connectivity of this toxin is not like that of α-conotoxins (C ). Therefore, this conotoxin was designated mr1e. According to the classical nomenclature of Conus peptides [1] , the two small letters "mr" represent the Conus species from which the conotoxin was identified, number 1 indicates the disulfide framework, and the letter "e" indicates the order of discovery. Before the identification of this peptide, four conotoxins with a CC-C-C framework had been purified from C. marmoreus, namely χ-MrIA (also termed CMrVIB or mr10e in different publications), χ-MrIB, CMrVIA, and CMrX [11, 13, 14] . However, the nomenclature of these peptides is rather confused. Following the suggestion of Jimenez et al [15] , these four conotoxins should all use number 1 for the cysteine framework and could be named sequentially as MrIA, MrIB, MrIC and MrID.
Assignment of disulfide pattern of mr1e
Although mr1e has a typical α-conotoxin cysteine framework, its sequence does not share the conserved Pro residue at the third position in the first intercysteine loop of α-conotoxins. To clarify the disulfide bond connectivity of mr1e, two isomers of mr1e with different disulfide pairing were chemically synthesized and selectively oxidized. We did not synthesize the isomer with C (Fig. 2) , which clearly indicates that mr1e has the same topological fold as χ-conotoxins.
Bioassay
Intracranial injection into mice showed that mr1e has an excitatory effect. When 25 μg mr1e were injected, the mice looked agitated which lasted for about 30 min without obvious behavior symptom. But injection of 100 μg mr1e immediately elicited stiffening of the body which lasted for about 10 min. Until 30 min after injection, the mice could not move due to the rigid paralysis of the rear legs. All the injected mice recovered after 30 min (data not shown). 
Discussion
In this paper, we report the purification and characterization of a novel conotoxin, mr1e, from the venom of C. marmoreus. This toxin might present a new family of conotoxins because it shares the same cysteine framework as α4/3 conotoxins but adopts distinct disulfide connectivity. mr1e is composed of only 11 residues, four of which are cysteines in a CC-C-C pattern. The spacing of the intercysteine loops is exactly the same as α4/3 conotoxins, but mr1e does not show any sequence homology with other α4/3 conotoxins. In particular, mr1e does not have Pro at the third position in the first intercysteine loop, which is highly conserved in all the published α-conotoxins. This Pro residue proved to be critical for the globular disulfide pairing of α-conotoxins (C , C 2 -C 3 ) [13] . Thus, the clarification of the disulfide pairing of mr1e became the primary interest.
Indeed, mr1e has a ribbon disulfide connectivity (
, like previously reported χ-conotoxins ( Table  1) . χ-Conotoxins constitute a unique family of conotoxins and act on a special target noradrenaline transporter [11] . Interestingly, all the χ-conotoxins identified so far, as well as mr1e, are from the same species, C. marmoreus. Sequence comparison clearly showed that mr1e has distinct features compared with χ-conotoxins. First, the spacing of the second intercysteine loop is different. There are three residues in this loop of mr1e, but only two residues exist in the corresponding loop of χ-conotoxins, and the second residue hydroxyproline is highly conserved. Second, the sequence of the first intercysteine loop is also significantly different between mr1e and other χ-conotoxins. Based on the Ala-scanning study of χ-MrIA, the residues in this loop are all of great importance for the activity or structure of this toxin [14] . It would thus be plausible to speculate that mr1e might have a different biological function. The bioactivity of mr1e was preliminarily explored by intracranial injection into mice, a method popularly used for conotoxin studies [20, 21, 22, 23] . The descriptive behavior symptoms induced by different conotoxins are often taken as qualitative and suggestive information for further study [21, 23] . The injection bioassay showed that mr1e could induce an excitatory effect on mice. The symptoms produced by mr1e are similar to those induced by CMrVIA [16] , but their potencies are certainly at different levels. CMrVIA is lethal at a dosage of 40 ng/g body weight, but mice can survive mr1e even up to approximately 5 μg/g. Their effective pathways might be totally different. It would be very interesting to identify the molecular target of mr1e and explore the relationships between the biological activity and the unique structure of mr1e.
Conotoxins are well known for their extremely diversified structures and functions, easily seen by comparing the two-disulfide-bond conotoxins described in Table 1 . These toxins possess typically 10−19 residues including four cysteines. However, they show highly divergent cysteine frameworks, disulfide pairing, non-cysteine sequences, and biological functions. Furthermore, the same cysteine framework could form different disulfide connectivities, such as the contrast between mr1e and α4/3 conotoxin. Toxins with the same disulfide linkage might have different targets and functions. For instance, ρ-TIA has the same topological fold as α4/7 conotoxin, but it targets adrenoreceptors instead of acetylcholine receptors. The mechanism of the diversity of conotoxins is still unclear. The identification of mr1e certainly enriches our understanding of conotoxins, and also opens the way for further structural and functional investigation. 
